Atlas Trials

Efficacy of Gut-Brain Neuromodulators in the Treatment of Gastroesophageal Reflux Disease

Clinical trial NCT06945237 · COMPLETED

Trial details

NCT number
NCT06945237
Sponsor
RenJi Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Gastroesophageal Reflux Disease
Start date
2025-04-24
Primary completion
2025-08-01
Enrollment
164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.